[1] FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. International Journal of Cancer, 2015, 136(5): 359-386.
[2] GRAYSON M.Bladder cancer[J]. Nature, 2017, 551(7679): S33.
[3] CHEN Z Y, WANG Y X, YANG F, et al.New researches and application progress of commonly used optical molecular imaging technology[J]. BioMed Research International, 2014, 2014: 1-22.
[4] MAURIZI L, PAPA A L, DUMONT L, et al.Influence of surface charge and polymer coating on internalization and biodistribution of polyethylene glycol-modified iron oxide nanoparticles[J]. Journal of Biomedical Nanotechnology, 2015, 11(1): 126-136.
[5] GUO Z Q, ZOU Y L, HE H, et al.Bifunctional platinated nanoparticles for photoinduced tumor ablation[J]. Advanced Materials, 2016, 28(46): 10155-10164.
[6] FERRARI M.Cancer nanotechnology: opportunities and challenges[J]. Nature Reviews Cancer, 2005, 5(3): 161-171.
[7] KAWASHIMA Y.Nanoparticulate systems for improved drug delivery[J]. Advanced Drug Delivery Reviews, 2001, 47(1): 1-2.
[8] LIU Z, DAVIS C, CAI W, et al.Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy[J]. Proceedings of the National Academy of Sciences, 2008, 105(5): 1410-1415.
[9] DONKOR D A, TANG X S.Tube length and cell type-dependent cellular responses to ultra-short single-walled carbon nanotube[J]. Biomaterials, 2014, 35(9): 3121-3131.
[10] LACERDA L, BIANCO A, PRATO M, et al.Carbon nanotubes as nanomedicines: from toxicology to pharmacology[J]. Advanced Drug Delivery Reviews, 2006, 58(14): 1460-1470.
[11] SWIERCZEWSKA M, CHOI K Y, MERTZ E L, et al.A facile, one-step nanocarbon functionalization for biomedical applications[J]. Nano Letters, 2012, 12(7): 3613-3620.
[12] CHEN C Q, HOU L, ZHANG H J, et al.Single-walled carbon nanotubes mediated targeted tamoxifen delivery system using aspargine-glycine-arginine peptide[J]. Journal of Drug Targeting, 2013, 21(9): 809-821.
[13] SHAO W, PAUL A, ZHAO B, et al.Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model[J]. Biomaterials, 2013, 34(38): 10109-10119.
[14] COOK A D, HAMILTON J A.Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab[J]. Therapeutic Advances in Musculoskeletal Disease, 2018, 10(2): 29-38.
[15] HAMILTON J A, COOK A D, TAK P P.Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases[J]. Nature Reviews Drug Discovery, 2017, 16(1): 53-70.
[16] HAMILTON J A, STANLEY E R, BURGESS A W, et al.Stimulation of macrophage plasminogen activator activity by colony-stimulating factors[J]. Journal of Cellular Physiology, 1980, 103(3): 435-445.
[17] HAMILTON J A.GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential[J]. Expert Review of Clinical Immunology, 2015, 11(4): 457-465.
[18] MARQUES-ALEIXO I, SANTOS-ALVES E, OLIVEIRA P J, et al.The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2018, 1869(2): 189-199. |
